- Post-Effective Amendment to Registration Statement (POS AM)
September 17 2009 - 11:46AM
Edgar (US Regulatory)
Registration No. 333-132273
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1
to
FORM S-3
REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933
NYER MEDICAL GROUP, INC.
(Exact Name of Registrant as Specified in Its Charter)
Florida
|
|
04-0469607
|
(State or Other Jurisdiction of Incorporation or
Organization)
|
|
(I.R.S. Employer Identification No.)
|
13 Water
Street
Holliston,
Massachusetts 01746
(508) 429-8506
(Address,
including zip code, and telephone number, including area code, of registrants
principal executive offices)
Mark Dumouchel, President
Nyer Medical Group, Inc.
13 Water Street
Holliston, Massachusetts 01746
(508)
429-8506
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copy to:
Howard E. Berkenblit, Esq.
Sullivan & Worcester LLP
One Post Office Square
Boston, Massachusetts 02109
(617) 338-2800
Approximate
date of commencement of proposed sale to the public:
Not applicable.
If the only
securities being registered on this form are being offered pursuant to dividend
or interest reinvestment plans, please check the following box.
o
If any of the
securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933,
other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box.
o
If this Form is
filed to register additional securities for an offering pursuant to Rule 462(b) under
the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering.
o
If this Form is
a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering.
o
If this Form is
a registration statement pursuant to General Instruction I.D. or a
post-effective amendment thereto that shall become effective upon filing with
the Commission pursuant to Rule 462(e) under the Securities Act,
check the following box.
o
If this Form is
a post-effective amendment to a registration statement filed pursuant to
General Instruction I.D. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities
Act, check the following box.
o
DEREGISTRATION OF UNSOLD SHARES OF
COMMON STOCK
On March 8, 2006, Nyer Medical Group, Inc.
(the Company) filed a Registration Statement on Form S-3 (Registration No. 333-132273)
(the Registration Statement) for resales of an aggregate of 150,000 shares of
common stock, par value $.0001 per share, of the Company, issuable upon the
exercise of stock options granted to the selling securityholder. This Post-Effective Amendment No. 1 is
being filed by the Company pursuant to the Companys undertaking in accordance
with the Registration Statement to deregister all 150,000 shares of common
stock registered pursuant to the Registration Statement, or such lesser portion
that have not been sold or transferred pursuant to the Registration Statement
as of the date this Post-Effective Amendment No. 1 is filed. The contractual obligations between the
Company and the selling securityholder named in the Registration Statement
requiring the Registration Statement to remain effective have expired by their
terms.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of
1933, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-3, and has duly
caused this Post-Effective Amendment No. 1 to the Registration Statement
to be signed on its behalf by the undersigned, thereunto duly authorized, in
the City of Holliston, Commonwealth of Massachusetts, as of the 17
th
day of
September, 2009.
|
Nyer
Medical Group, Inc.
|
|
|
|
|
|
|
|
By:
|
/s/ Mark Dumouchel
|
|
|
Name:
|
Mark Dumouchel
|
|
|
Title:
|
President and
Chief Executive Officer
|
Pursuant to the requirements of the Securities Act
of 1933, as amended, this Post-Effective Amendment No. 1 to the
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
/s/ David Dumouchel
|
|
Director
|
|
September 17, 2009
|
David Dumouchel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Robert J. Landis
|
|
Director
|
|
September 17, 2009
|
Robert J. Landis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ James Schweiger
|
|
Director
|
|
September 17, 2009
|
James Schweiger
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Gerald Weston
|
|
Director
|
|
September 17, 2009
|
Gerald Weston
|
|
|
|
|
3
Nyer Medical (NASDAQ:NYER)
Historical Stock Chart
From Apr 2024 to May 2024
Nyer Medical (NASDAQ:NYER)
Historical Stock Chart
From May 2023 to May 2024